Searched for
MULTINATIONAL PHARMACEUTICAL FIRMS
India Inc's green transition triggers hiring surgeAs organisations step up their sustainability efforts, demand is also growing for senior leadership talent, including business heads for re...
Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...
Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
China's plans to import Indian drugs fail to enthuse Indian pharmaceutical firmsOn May 4, China said it had removed import duties on as many as 28 medicines, but the need for lengthy trials and approvals has dampened en...
Ranbaxy's global HR head Udbhav Ganjoo quits, may join Mylan: SourcesHe has been a member of Ranbaxy's executive committee and has held positions on boards of various overseas subsidiaries of the pharma major.
Dose of bitter pills, few booster injections for pharma sectorThe pharma sector, estimated to be around Rs 1.5 lakh cr, recorded single digit growth for the first time in many years on account of deepe...
Is FDI in pharma giving desired results, wonders DIPPThe DIPP said current norms must lay down the foundation of what should be the nature of Indian drug companies in the long term.
- DIPP wants relook of FDI policy in pharma at PM level
With no let up in multinationals seeking nod to acquire stake in Indian pharma firms despite government putting norms to check it.
- GSK Pharma: Investors must be careful of the competitive threats it faces in India
While the company's performance in the June quarter was strong sequentially, it will be interesting to see GSK's strategies to overcome the...
- Govt mulls tighter pharma FDI norms
Worried over the spate of takeover of Indian pharmaceutical companies by multinational firms, the government has set up a panel to study th...
- Indian drugmakers gear up to challenge frivolous MNC patents
Leading domestic drugmakers have decided to collectively challenge frivolous patent applications filed by multinationals in India under the...
- India to WIPO chief: MNCs working against Indian drug firms
India on Wednesday complained to the UN intellectual property rights body, WIPO, that some multinational firms have launched campaign again...
- India to move WTO against EU MNCs blocking its generics
India, along with Brazil, will lodge a complaint with the WTO against the European Union, alleging that Europe-based multinational pharmace...
- Govt not to allow trials for drugs developed outside India
The health ministry will put on hold its plans to grant permissions to multinational pharma firms for conducting phase I clinical trials of...
- Sun gets notice for from Taro for termination of merger pact
Domestic drug firm Sun Pharmaceutical, which had acquired Israel-based Taro Pharma for 455 million dollar last year, today said the Israel-...
- Asia Pacific hot zone for pharma
A third of Asia’s drugmakers want to buy other pharmaceutical companies as they seek a bigger share of the $643 billion global market, a ne...
- India, China to lead pharma growth in Asia: PWC
India and China will drive the growth in Asia's pharmaceutical industry as the continent gears up to become the centre of the global pharma...